1. Home
  2. FND vs INAB Comparison

FND vs INAB Comparison

Compare FND & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Floor & Decor Holdings Inc.

FND

Floor & Decor Holdings Inc.

HOLD

Current Price

$51.66

Market Cap

5.3B

ML Signal

HOLD

Logo IN8bio Inc.

INAB

IN8bio Inc.

HOLD

Current Price

$1.86

Market Cap

15.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FND
INAB
Founded
2000
2016
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
15.6M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
FND
INAB
Price
$51.66
$1.86
Analyst Decision
Buy
Strong Buy
Analyst Count
16
1
Target Price
$73.44
$6.00
AVG Volume (30 Days)
3.3M
60.3K
Earning Date
04-30-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
1.05
N/A
EPS
0.37
N/A
Revenue
$4,684,088,000.00
N/A
Revenue This Year
$7.53
N/A
Revenue Next Year
$7.68
N/A
P/E Ratio
$139.15
N/A
Revenue Growth
5.12
N/A
52 Week Low
$42.64
$1.17
52 Week High
$92.41
$4.20

Technical Indicators

Market Signals
Indicator
FND
INAB
Relative Strength Index (RSI) 57.66 68.74
Support Level $46.50 $1.52
Resistance Level $53.50 $2.14
Average True Range (ATR) 2.47 0.10
MACD 0.78 0.03
Stochastic Oscillator 91.08 95.85

Price Performance

Historical Comparison
FND
INAB

About FND Floor & Decor Holdings Inc.

Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site. The company segments include retail segment and others.

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.

Share on Social Networks: